Aptus Capital Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$627K Buy
2,241
+42
+2% +$11K ﹤0.01% 729
2026
Q1
$587K Buy
2,199
+16
+0.7% +$4.33K ﹤0.01% 678
2025
Q4
$548K Buy
2,183
+149
+7% +$39.6K ﹤0.01% 708
2025
Q3
$584K Sell
2,034
-404
-17% -$108K ﹤0.01% 668
2025
Q2
$640K Buy
2,438
+440
+22% +$107K 0.01% 626
2025
Q1
$465K Buy
1,998
+17
+0.9% +$4.13K ﹤0.01% 659
2024
Q4
$454K Buy
1,981
+62
+3% +$14.2K ﹤0.01% 660
2024
Q3
$429K Sell
1,919
-8
-0.4% -$1.76K 0.01% 578
2024
Q2
$392K Sell
1,927
-15
-0.8% -$3.05K 0.01% 552
2024
Q1
$424K Buy
1,942
+59
+3% +$13K 0.01% 550
2023
Q4
$428K Sell
1,883
-70
-4% -$14.7K 0.01% 408
2023
Q3
$393K Buy
1,953
+1,948
+38,960% +$411K 0.01% 431
2023
Q2
$965 Sell
5
-2,628
-100% -$510K ﹤0.01% 782
2023
Q1
$519K Sell
2,633
-2,044
-44% -$421K 0.01% 320
2022
Q4
$946K Sell
4,677
-713
-13% -$139K 0.03% 280
2022
Q3
$949K Buy
5,390
+3,205
+147% +$656K 0.02% 268
2022
Q2
$440K Sell
2,185
-158
-7% -$33.7K 0.01% 289
2022
Q1
$531K Buy
2,343
+1,253
+115% +$295K 0.01% 302
2021
Q4
$294K Hold
1,090
0.01% 318
2021
Q3
$263K Hold
1,090
0.01% 324
2021
Q2
$258K Sell
1,090
-2
-0.2% -$456 0.01% 332
2021
Q1
$239K Buy
+1,092
New +$219K 0.01% 315

Other funds holding LH

Aptus Capital Advisors's LH Position: Q2 2026 in Review

Aptus Capital Advisors increased its Labcorp (LH) stake by 1.9% in Q2 2026, buying an estimated $11K and bringing the position to 2,241 shares worth $627K. The position accounts for ﹤0.01% of the portfolio, ranked #729.

Aptus Capital Advisors first reported a position in LH in Q1 2021 and has held it in 22 quarters since. The position peaked at $949K in Q3 2022. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Aptus Capital Advisors held 2,241 shares of Labcorp worth $627K as of Q2 2026.
  • Aptus Capital Advisors bought 42 Labcorp shares in Q2 2026, an estimated $11K.
  • Labcorp made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #729 holding.
  • Aptus Capital Advisors first reported a position in Labcorp in Q1 2021 and has held it in 22 quarters since.
  • Aptus Capital Advisors's Labcorp position peaked at $949K in Q3 2022.
  • 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.